drugset / Trial / NCT01099839

A Study to Assess Drug-Drug Interaction Between ASP1941 and Miglitol

NCT01099839

Phase 1 Completed 30 enrolled Astellas Pharma Inc
RandomizedCrossoverOpen-label

Summary

This study is to assess the pharmacokinetic interaction between ASP1941 and Miglitol in healthy volunteers.

Timeline

Start
2010-02
Primary completion
2010-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Miglitol Small molecule Oral
Subject ipragliflozin Small molecule Oral

Indications

No indication recorded.